ici 118551 and vatalanib

ici 118551 has been researched along with vatalanib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, S; Ji, Y; Li, K; Xiao, X; Xu, T; Zheng, S	1

Other Studies

1 other study(ies) available for ici 118551 and vatalanib

Article	Year
Upregulated autocrine vascular endothelial growth factor (VEGF)/VEGF receptor-2 loop prevents apoptosis in haemangioma-derived endothelial cells. The British journal of dermatology, 2014, Volume: 170, Issue:1 Topics: Adrenergic beta-Antagonists; Angiogenesis Inhibitors; Apoptosis; Cell Survival; Culture Media, Serum-Free; Endothelial Cells; Hemangioma; Human Umbilical Vein Endothelial Cells; Humans; Phthalazines; Propanolamines; Propranolol; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Pyridines; Up-Regulation; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2	2014

Article

Year

Upregulated autocrine vascular endothelial growth factor (VEGF)/VEGF receptor-2 loop prevents apoptosis in haemangioma-derived endothelial cells.

The British journal of dermatology, 2014, Volume: 170, Issue:1

Topics: Adrenergic beta-Antagonists; Angiogenesis Inhibitors; Apoptosis; Cell Survival; Culture Media, Serum-Free; Endothelial Cells; Hemangioma; Human Umbilical Vein Endothelial Cells; Humans; Phthalazines; Propanolamines; Propranolol; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Pyridines; Up-Regulation; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2

2014